These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2487379)

  • 1. Mechanism of antigenic variation in Shigella flexneri bacilli. I. Selective lethal effect of normal sera on mixed population of S. flexneri 1b serotype and its antigenic 3b mutant.
    Doroszkiewicz W; Lachowicz TM
    Arch Immunol Ther Exp (Warsz); 1989; 37(5-6):693-701. PubMed ID: 2487379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of antigenic variation in Shigella flexneri. II. Sensitivity to complement as a selection factor for antigenic mutant 3b in 1b serotype.
    Doroszkiewicz W; Pokłaldek R; Lachowicz TM
    Arch Immunol Ther Exp (Warsz); 1994; 42(2):155-8. PubMed ID: 7503650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bacterial antigenic structure of Shigella flexneri serotype 1B and its 3B serotype mutant and susceptibility to bacterial action of complement in normal bovine serum].
    Doroszkiewicz W; Lachowicz TM
    Postepy Hig Med Dosw; 1996; 50(5):519-23. PubMed ID: 9072769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of antigenic variation in Shigella flexneri bacilli. III. Complement sensitivity of S. flexneri 1b strains and their 3b variants selected either as Lac+ recombinants or phage F2 resistant mutants.
    Doroszkiewicz W; Kopociński B; Lachowicz TM
    Arch Immunol Ther Exp (Warsz); 1995; 43(1):67-72. PubMed ID: 8744688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of antigenic variation in Shigella flexneri bacilli. IV. Role of lipopolysaccharides and their components in the sensitivity of Shigella flexneri 1b and its Lac+ recombinant to killing action of serum.
    Doroszkiewicz W
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):235-42. PubMed ID: 9597093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of some Shigella flexneri (Escherichia coli) hybrids in cross agglutination and agglutinin absorption tests.
    Lachowicz TM; Lagowska-Złotorzycka M; Czarny A; Kołodyński J
    Arch Immunol Ther Exp (Warsz); 1979; 27(5):693-9. PubMed ID: 398206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population dynamics in the co-culture of Shigella flexneri 1b original strain and its antigenic 3b mutant carrying a prophage.
    Lachowicz TM; Dziadkowiec D; Kopocińska I; Kopociński B
    Microbios; 1995; 83(335):89-106. PubMed ID: 8538494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic variability of Shigella flexneri serovars 1-5.
    Petrovskaya VG; Bondarenko VM
    Mol Gen Mikrobiol Virusol; 1995; (2):15-7. PubMed ID: 7477027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Shigella dysenteriae serotype 1 O-antigenic polysaccharide by Shigella flexneri aroD vaccine candidates and different S. flexneri serotypes.
    Fält IC; Schweda EK; Klee S; Singh M; Floderus E; Timmis KN; Lindberg AA
    J Bacteriol; 1995 Sep; 177(18):5310-5. PubMed ID: 7545156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of Shigella strains to the bactericidal activity of human serum. II. Shigella flexneri 3 a is killed by complement activated via the classical pathway, with participation of lysozyme.
    Mokracka-Latajka G; Grzybek-Hryncewicz K; Jankowski S
    Acta Microbiol Pol; 1990; 39(3-4):117-20. PubMed ID: 1715645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of Shigella strains to the bactericidal activity of human serum. III. The diversity of activity variants of bactericidal serum factors against Shigella flexneri serotypes.
    Mokracka-Latajka G; Grzybek-Hryncewicz K; Jankowski S
    Acta Microbiol Pol; 1990; 39(3-4):121-7. PubMed ID: 1715646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observations on the serologic changes in the recombinants in Shigella flexneri Serotype 4a.
    Lagowska-Zlotorzycka M; Durlakowa I; Jankowski S; Lachowicz TM
    Acta Microbiol Pol A; 1975; 7(1):3-9. PubMed ID: 1090112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antigenic analysis and identification of serotype for an arguable strain of Shigella].
    Yang Z
    Wei Sheng Wu Xue Bao; 1991 Dec; 31(6):466-72. PubMed ID: 1814048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the antigenic structure of S. flexneri 5 as a result of recombination.
    Lachowicz TM; Mulczyk M
    Arch Immunol Ther Exp (Warsz); 1971; 19(5):721-6. PubMed ID: 4952938
    [No Abstract]   [Full Text] [Related]  

  • 16. The Shigella flexneri serotype Y vaccine candidate SFL124 originated from a serotype 2a background.
    Roberts F; Jennison AV; Verma NK
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):285-9. PubMed ID: 15963704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AA479 antiserum: new reagent for the serotype characterization of atypical variants of Shigella flexneri.
    van der Ploeg CA; Rogé AD; Bordagorria XL; de Urquiza MT; Viñas MR; Pichel MG; Bruno SB
    Rev Argent Microbiol; 2015; 47(1):36-40. PubMed ID: 25735215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotype conversion of a Shigella flexneri candidate vaccine strain via a novel site-specific chromosome-integration system.
    Guan S; Verma NK
    FEMS Microbiol Lett; 1998 Sep; 166(1):79-87. PubMed ID: 9741086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Shigella flexneri-specific murine monoclonal antibodies by chemically defined glycoconjugates.
    Carlin NI; Gidney MA; Lindberg AA; Bundle DR
    J Immunol; 1986 Oct; 137(7):2361-6. PubMed ID: 3531329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity.
    Jennison AV; Roberts F; Verma NK
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):444-51. PubMed ID: 16553820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.